APOE and Alzheimer disease: The same bioengineered model was very recently used to investigate how HDL particles enriched in apoE reduce Aβ accumulation in the vascular walls and attenuate endothelial Aβ-induced inflammation, thus providing new insights into the peripheral role of HDL in AD, in particular, the fraction of HDL that contains apoE [89].